Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Thoracic 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 12Diarrhea 3Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Colorectal Neoplasms 1Colitis 1

Interventions

Loperamide 3Probiotics 1Octreotide 1Lapatinib 1Fecal Microbiota Transplantation 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diarrhea × Loperamide × Breast × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
308 enrolled
Breast

Breast Neoplasms, Diarrhea

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Unknown
470 enrolled
Breast

Breast Neoplasms, Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡